Skip to content

Drug interactions

Amlodipine-olmesartan + Lenacapavir

Severity: Moderate

Amlodipine-olmesartan and Lenacapavir: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lenacapavir is a moderate CYP3A4 inhibitor and may raise amlodipine exposure, leading to hypotension and edema. The inhibition may persist for months after the last subcutaneous dose.

What this interaction means in plain words

Amlodipine-olmesartan and Lenacapavir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Amlodipine-olmesartan belongs to Cardiovascular; Lenacapavir belongs to Anti Virals.

Evidence level: Moderate

Why it happens

Lenacapavir inhibition of CYP3A4 reduces amlodipine metabolism.

What to do

Monitor blood pressure and edema, including after lenacapavir discontinuation. Reduce the amlodipine dose if adverse effects develop.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Amlodipine-olmesartan and Lenacapavir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Amlodipine-olmesartan with Lenacapavir?

MediHelp rates the interaction as moderate. Amlodipine-olmesartan and Lenacapavir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lenacapavir is a moderate CYP3A4 inhibitor and may raise amlodipine exposure, leading to hypotension and edema. The inhibition may persist for months after the last subcutaneous dose.

How serious is the interaction between Amlodipine-olmesartan and Lenacapavir?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood pressure and edema, including after lenacapavir discontinuation. Reduce the amlodipine dose if adverse effects develop.

What other medicines interact with Amlodipine-olmesartan?

MediHelp also lists interactions of Amlodipine-olmesartan with, for example, Aliskiren, Sparsentan, Amifostine. The full list is on the Amlodipine-olmesartan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in